this Book Showcases The Development And Evaluation Of Innovative Examples Of Pain Management Initiatives By Advanced Practitioners. It Considers Each Service Development Or Community Initiative Both In Terms Of Advanced Practice Nursing And Pain Management. There Is A Wide Range Of Examples Of Innov
The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain
✍ Scribed by Richard J. Clark; Jonas Jensen; Simon T. Nevin; Brid P. Callaghan; David J. Adams; David J. Craik
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 495 KB
- Volume
- 122
- Category
- Article
- ISSN
- 0044-8249
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Because malignant transformation of dysplastic oral leukoplakia has been reported in up to 43% of cases, these lesions must be managed. ## METHODS. This study evaluated the use of topical 1% bleomycin in dimethylsulfoxide for the treatment of dysplastic oral lesions. Bleomycin wa
Tiagabine HCl [(R]-N-[4,4-bis(3-methyl-2-thienyl]-3-butenyl] nipecotic acid hydrochloride], a potent and selective GABA uptake inhibitor, was evaluated for potential anti-allodynic effects in a rodent model of neuropathic pain and for antinociceptive activity in rodent models of acute and persistent
The synthesis of [3H]L-734,217, lb, an orally active fibrinogen receptor antagonist, is described. The conversion of 3-amino crotonate 6 to [3H]L-734,217 was carried out via a two step sequence of catalytic tritiation followed by basic hydrolysis. Deuterium model reactions showed that the reduction